116 related articles for article (PubMed ID: 34765725)
1. Inference of Sojourn Time and Transition Density using the NLST X-ray Screening Data in Lung Cancer.
Rahman F; Wu D
Med Res Arch; 2021 May; 9(5):. PubMed ID: 34765725
[TBL] [Abstract][Full Text] [Related]
2. Sojourn time and lead time projection in lung cancer screening.
Wu D; Erwin D; Rosner GL
Lung Cancer; 2011 Jun; 72(3):322-6. PubMed ID: 21075475
[TBL] [Abstract][Full Text] [Related]
3. Inference of Onset Age of Preclinical State and Sojourn Time for Breast Cancer.
Wu D; Kim S
Med Res Arch; 2022 Feb; 10(2):. PubMed ID: 35419489
[TBL] [Abstract][Full Text] [Related]
4. Estimation of Preclinical State Onset Age and Sojourn Time for Heavy Smokers in Lung Cancer.
Wu D; Rai SN; Seow A
Stat Interface; 2022; 15(3):349-358. PubMed ID: 35936652
[TBL] [Abstract][Full Text] [Related]
5. Estimation of sensitivity depending on sojourn time and time spent in preclinical state.
Kim S; Wu D
Stat Methods Med Res; 2016 Apr; 25(2):728-40. PubMed ID: 23129110
[TBL] [Abstract][Full Text] [Related]
6. Estimating key parameters in FOBT screening for colorectal cancer.
Wu D; Erwin D; Rosner GL
Cancer Causes Control; 2009 Feb; 20(1):41-6. PubMed ID: 18704710
[TBL] [Abstract][Full Text] [Related]
7. A Bayesian model for estimating multi-state disease progression.
Shen S; Han SX; Petousis P; Weiss RE; Meng F; Bui AA; Hsu W
Comput Biol Med; 2017 Feb; 81():111-120. PubMed ID: 28038345
[TBL] [Abstract][Full Text] [Related]
8. Estimating age group-dependent sensitivity and mean sojourn time in colorectal cancer screening.
Sung NY; Jun JK; Kim YN; Jung I; Park S; Kim GR; Nam CM
J Med Screen; 2019 Mar; 26(1):19-25. PubMed ID: 30261804
[TBL] [Abstract][Full Text] [Related]
9. Estimating key parameters in periodic breast cancer screening-application to the Canadian National Breast Screening Study data.
Chen Y; Brock G; Wu D
Cancer Epidemiol; 2010 Aug; 34(4):429-33. PubMed ID: 20434974
[TBL] [Abstract][Full Text] [Related]
10. A Bayesian nonlinear mixed-effects disease progression model.
Kim S; Jang H; Wu D; Abrams J
J Biom Biostat; 2015 Dec; 6(5):. PubMed ID: 26798562
[TBL] [Abstract][Full Text] [Related]
11. Estimation of semi-Markov multi-state models: a comparison of the sojourn times and transition intensities approaches.
Asanjarani A; Liquet B; Nazarathy Y
Int J Biostat; 2021 Jan; 18(1):243-262. PubMed ID: 35641138
[TBL] [Abstract][Full Text] [Related]
12. Robust modeling in screening studies: estimation of sensitivity and preclinical sojourn time distribution.
Shen Y; Zelen M
Biostatistics; 2005 Oct; 6(4):604-14. PubMed ID: 15860542
[TBL] [Abstract][Full Text] [Related]
13. When to initiate cancer screening exam?
Wu D
Stat Interface; 2022; 15(4):503-514. PubMed ID: 36051671
[TBL] [Abstract][Full Text] [Related]
14. Estimation of mean sojourn time in breast cancer screening using a Markov chain model of both entry to and exit from the preclinical detectable phase.
Duffy SW; Chen HH; Tabar L; Day NE
Stat Med; 1995 Jul; 14(14):1531-43. PubMed ID: 7481190
[TBL] [Abstract][Full Text] [Related]
15. The Impact of Model Assumptions on Personalized Lung Cancer Screening Recommendations.
Ten Haaf K; de Nijs K; Simoni G; Alban A; Cao P; Sun Z; Yong J; Jeon J; Toumazis I; Han SS; Gazelle GS; Kong CY; Plevritis SK; Meza R; de Koning HJ
Med Decis Making; 2024 May; ():272989X241249182. PubMed ID: 38738534
[TBL] [Abstract][Full Text] [Related]
16. Bayesian evaluation of breast cancer screening using data from two studies.
Myles JP; Nixon RM; Duffy SW; Tabar L; Boggis C; Evans G; Shenton A; Howell A
Stat Med; 2003 May; 22(10):1661-74. PubMed ID: 12720303
[TBL] [Abstract][Full Text] [Related]
17. Estimation of mean sojourn time for lung cancer by chest X-ray screening with a Bayesian approach.
Chien CR; Lai MS; Chen TH
Lung Cancer; 2008 Nov; 62(2):215-20. PubMed ID: 18400331
[TBL] [Abstract][Full Text] [Related]
18. Estimation of the tumor size at cure threshold among aggressive non-small cell lung cancers (NSCLCs): evidence from the surveillance, epidemiology, and end results (SEER) program and the national lung screening trial (NLST).
Goldwasser DL
Int J Cancer; 2017 Mar; 140(6):1280-1292. PubMed ID: 27925181
[TBL] [Abstract][Full Text] [Related]
19. Mean sojourn time and effectiveness of mortality reduction for lung cancer screening with computed tomography.
Chien CR; Chen TH
Int J Cancer; 2008 Jun; 122(11):2594-9. PubMed ID: 18302157
[TBL] [Abstract][Full Text] [Related]
20. Estimation of sojourn time in chronic disease screening without data on interval cases.
Chen TH; Kuo HS; Yen MF; Lai MS; Tabar L; Duffy SW
Biometrics; 2000 Mar; 56(1):167-72. PubMed ID: 10783792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
